Natixis’s QuidelOrtho QDEL Stock Holding History

Natixis’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,807	Closed	-$969K	–	1143
2025 Q1	$969K	Buy	+27,807	New	+$1.13M	0.01%	560
2022 Q2	–	Sell	-131,145	Closed	-$14.7M	–	1319
2022 Q1	$14.7M	Buy	+131,145	New	+$14M	0.05%	322

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Natixis's QDEL Position: Q2 2025 in Review

Natixis sold out of QuidelOrtho (QDEL) in Q2 2025, closing a stake of 27,807 shares — an estimated $969K sold.

Natixis first reported a position in QDEL in Q1 2022 and held it in 2 quarters. The position peaked at $14.7M in Q1 2022. 264 funds tracked by Wall St. Rank hold QDEL as of Q2 2025.

Natixis reported no remaining QuidelOrtho position as of Q2 2025 after selling out during the quarter.
Natixis sold 27,807 QuidelOrtho shares in Q2 2025, an estimated $969K.
Natixis first reported a position in QuidelOrtho in Q1 2022 and held it in 2 quarters.
Natixis's QuidelOrtho position peaked at $14.7M in Q1 2022.
264 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2025.

Based on Natixis's 13F filing for Q2 2025, filed 13 Aug 2025.